1-10 of 10
Elisabetta Marangoni
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract P215: The MDM2 inhibitor milademetan induces synthetic lethality in GATA3 mutant, ER positive breast cancer

Vijaya G. Tirunagaru, Gaia Bianco, Charlotte K. Y. Ng, Elisabetta Marangoni, Salvatore Piscuoglio, François-Clément Bidard, Robert C. Doebele
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (12_Supplement): P215.
DOI: https://doi.org/10.1158/1535-7163.TARG-21-P215
Published: 01 December 2021
View article
Journal Articles

Chromatin Regulators as a Guide for Cancer Treatment Choice

Zachary A. Gurard-Levin, Laurence O.W. Wilson, Vera Pancaldi, Sophie Postel-Vinay, Fabricio G. Sousa, Cecile Reyes, Elisabetta Marangoni, David Gentien, Alfonso Valencia, Yves Pommier, Paul Cottu, Geneviève Almouzni
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2016) 15 (7): 1768–1777.
DOI: https://doi.org/10.1158/1535-7163.MCT-15-1008
Published: 05 July 2016
View article
PDF
Includes: Supplementary data
Journal Articles

AKT Antagonist AZD5363 Influences Estrogen Receptor Function in Endocrine-Resistant Breast Cancer and Synergizes with Fulvestrant (ICI182780) In Vivo

Ricardo Ribas, Sunil Pancholi, Stephanie K. Guest, Elisabetta Marangoni, Qiong Gao, Aurélie Thuleau, Nikiana Simigdala, Urszula M. Polanska, Hayley Campbell, Aradhana Rani, Gianmaria Liccardi, Stephen Johnston, Barry R. Davies, Mitch Dowsett, Lesley-Ann Martin
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (9): 2035–2048.
DOI: https://doi.org/10.1158/1535-7163.MCT-15-0143
Published: 02 September 2015
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract C174: Establishment of luminal breast cancer patient-derived xenografts with acquired resistance to both hormonotherapy and everolimus.

Rania El Botty, Paul Cottu, Franck Assayag, Pierre de la Grange, David Gentien, Aurélie Thuleau, Sophie Vacher, Sophie Chateau-Joubert, Ivan Bièche, Elisabetta Marangoni
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): C174.
DOI: https://doi.org/10.1158/1535-7163.TARG-13-C174
Published: 01 November 2013
View article
Journal Articles

Abstract A8: The EurOPDX consortium: Sharing patient tumor-derived xenografts for collaborative multicentric preclinical trials.

Emilie Vinolo, Elisabetta Marangoni, Violeta Serra, Frederic Amant, Andrea Bertotti, Andrew V. Biankin, Anne-Lise Børresen-Dale, Alejandra Bruna, Eva Budinská, Annette Byrne, Carlos Caldas, David Chang, Robert Clarke, Els Hermans, Manuel Hidalgo, Steven de Jong, Jos Jonkers, Pedro López, Gunhild Mari Mælandsmo, Vlad Popovici, Sergio Roman-Roman, Joan Seoane, Livio Trusolino, Alberto Villanueva
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): A8.
DOI: https://doi.org/10.1158/1535-7163.TARG-13-A8
Published: 01 November 2013
View article
Journal Articles

Abstract A9: Establishment and characterization of residual breast cancer patient-derived xenografts resistant to neo-adjuvant therapy.

Elisabetta Marangoni, Dalila Labiod, Franck Assayag, Rania El Botty, Rana Hatem, Sophie Richon, Sophie Chateau-Joubert, Marine Carlus, Hélène Bonsang-Kitzis, Alice Pinheiro, Cécile Laurent, Ivan Bièche, Fabien Reyal
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): A9.
DOI: https://doi.org/10.1158/1535-7163.TARG-13-A9
Published: 01 November 2013
View article
Journal Articles

Inhibiting Aurora Kinases Reduces Tumor Growth and Suppresses Tumor Recurrence after Chemotherapy in Patient-Derived Triple-Negative Breast Cancer Xenografts

Angela Romanelli, Anderson Clark, Franck Assayag, Sophie Chateau-Joubert, Marie-France Poupon, Jean-Luc Servely, Jean-Jacques Fontaine, Xiaohong Liu, Edward Spooner, Samantha Goodstal, Patricia de Cremoux, Ivan Bièche, Didier Decaudin, Elisabetta Marangoni
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2012) 11 (12): 2693–2703.
DOI: https://doi.org/10.1158/1535-7163.MCT-12-0441-T
Published: 09 December 2012
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract B11: A panel of patient-derived xenografts for preclinical efficacy studies in various breast cancer molecular subtypes.

Olivier Deas, Stefano Cairo, Victorine Boissay, Aurore Gorse, Christophe Ginestier, Emmanuelle Charafe-Jaufret, Elisabetta Marangoni, Didier Decaudin, Marie-France Poupon, Jean-Gabriel Judde
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (11_Supplement): B11.
DOI: https://doi.org/10.1158/1535-7163.TARG-11-B11
Published: 12 November 2011
View article
Journal Articles

Abstract A27: Efficacy of estramustine + docetaxel in docetaxel‐resistant human prostate cancer xenograft: a preclinical model of docetaxel resistance reversion

Ahmed Dahmani, Ludmilla De Plater, Charlotte Guyader, Jean‐Jacques Fontaine, Aurélie Berniard, Franck Assayag, Philippe Beuzeboc, Elisabetta Marangoni, Fariba Némati, Marie‐France Poupon, Christophe Pasik, Stéphane Oudard, Didier Decaudin
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): A27.
DOI: https://doi.org/10.1158/1535-7163.TARG-09-A27
Published: 10 December 2009
View article
Journal Articles

CD44-targeting inhibits tumor growth and prevents post-chemotherapy relapse in human breast cancer xenografts

Marie-France Poupon, Elisabetta Marangoni, Nicolas Lecomte, Florence Smadjia-Joffe, Gonzague DePinieux
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): A93.
Published: 01 November 2007
View article